Can somewhat agree, without seeing any actual data, that using a “healthier” donor t-cell could yield better results that using a patients potentially compromised t-cells. But in saying that, it’s the t-cells are the one that’s killer the cancer, is that what’s failing? Or is it a compromised t-cell that’s failing? Show me some data please
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.002(10.0%) |
Mkt cap ! $100.8M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $239.8K | 17.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 215150 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 657058 | 2 |
View Market Depth
| Last trade - 15.59pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |